
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 01, 2021, titled "Sun Pharma Announces Availability of WINLEVI�� (clascoterone) cream 1% in the U.S. for Topical Treatment of Acne Vulgaris".
Filed with NSE ·

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 01, 2021, titled "Sun Pharma Announces Availability of WINLEVI�� (clascoterone) cream 1% in the U.S. for Topical Treatment of Acne Vulgaris".
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries